<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2018-01-31" version="242">
<accession>P01009</accession>
<accession>A6PX14</accession>
<accession>B2RDQ8</accession>
<accession>Q0PVP5</accession>
<accession>Q13672</accession>
<accession>Q53XB8</accession>
<accession>Q5U0M1</accession>
<accession>Q7M4R2</accession>
<accession>Q86U18</accession>
<accession>Q86U19</accession>
<accession>Q96BF9</accession>
<accession>Q96ES1</accession>
<accession>Q9P1P0</accession>
<accession>Q9UCE6</accession>
<accession>Q9UCM3</accession>
<name>A1AT_HUMAN</name>
<protein>
<recommendedName>
<fullName>Alpha-1-antitrypsin</fullName>
</recommendedName>
<alternativeName>
<fullName>Alpha-1 protease inhibitor</fullName>
</alternativeName>
<alternativeName>
<fullName>Alpha-1-antiproteinase</fullName>
</alternativeName>
<alternativeName>
<fullName>Serpin A1</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>Short peptide from AAT</fullName>
<shortName>SPAAT</shortName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">SERPINA1</name>
<name type="synonym">AAT</name>
<name type="synonym">PI</name>
<name type="ORF">PRO0684</name>
<name type="ORF">PRO2209</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1983" name="DNA" volume="2" first="255" last="264">
<title>Cloning and expression in Escherichia coli of full-length complementary DNA coding for human alpha 1-antitrypsin.</title>
<authorList>
<person name="Bollen A."/>
<person name="Herzog A."/>
<person name="Cravador A."/>
<person name="Herion P."/>
<person name="Chuchana P."/>
<person name="van der Straten A."/>
<person name="Loriau R."/>
<person name="Jacobs P."/>
<person name="van Elsen A."/>
</authorList>
<dbReference type="PubMed" id="6319097"/>
<dbReference type="DOI" id="10.1089/dna.1983.2.255"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1984" name="Biochemistry" volume="23" first="4828" last="4837">
<title>Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant.</title>
<authorList>
<person name="Long G.L."/>
<person name="Chandra T."/>
<person name="Woo S.L.C."/>
<person name="Davie E.W."/>
<person name="Kurachi K."/>
</authorList>
<dbReference type="PubMed" id="6093867"/>
<dbReference type="DOI" id="10.1021/bi00316a003"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1984" name="Nature" volume="312" first="77" last="80">
<title>Synthesis in yeast of a functional oxidation-resistant mutant of human alpha-antitrypsin.</title>
<authorList>
<person name="Rosenberg S."/>
<person name="Barr P.J."/>
<person name="Najarian R.C."/>
<person name="Hallewell R.A."/>
</authorList>
<dbReference type="PubMed" id="6387509"/>
<dbReference type="DOI" id="10.1038/312077a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>MUTAGENESIS OF MET-382</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1985" name="Cell" volume="41" first="531" last="540">
<title>Cell-specific expression of a transfected human alpha 1-antitrypsin gene.</title>
<authorList>
<person name="Ciliberto G."/>
<person name="Dente L."/>
<person name="Cortese R."/>
</authorList>
<dbReference type="PubMed" id="2985281"/>
<dbReference type="DOI" id="10.1016/S0092-8674(85)80026-X"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1986" name="J. Biol. Chem." volume="261" first="15989" last="15994">
<title>Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene.</title>
<authorList>
<person name="Nukiwa T."/>
<person name="Satoh K."/>
<person name="Brantly M.L."/>
<person name="Ogushi F."/>
<person name="Fells G.A."/>
<person name="Courtney M."/>
<person name="Crystal R.G."/>
</authorList>
<dbReference type="PubMed" id="3491072"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>CHARACTERIZATION OF VARIANT Z</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1987" name="J. Biol. Chem." volume="262" first="10412" last="10412">
<authorList>
<person name="Nukiwa T."/>
<person name="Satoh K."/>
<person name="Brantly M.L."/>
<person name="Ogushi F."/>
<person name="Fells G.A."/>
<person name="Courtney M."/>
<person name="Crystal R.G."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2007" name="Indian J. Biochem. Biophys." volume="44" first="176" last="178">
<title>An alpha-1 antitrypsin genetic variant from India.</title>
<authorList>
<person name="Shasany A.K."/>
<person name="Shukla A.K."/>
<person name="Darokar M.P."/>
<person name="Saraiya M."/>
<person name="Chaturvedi N."/>
<person name="Tewari L."/>
<person name="Khanuja S.P."/>
</authorList>
<dbReference type="PubMed" id="17650587"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS ALA-237 AND ASP-400</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="8">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<title>Characterization of a new variant of alpha1 antitrypsin M Lille (p.Gly148Trp).</title>
<authorList>
<person name="Balduyck M."/>
<person name="Porchet N."/>
<person name="Aubert J.-P."/>
<person name="Zerimech F."/>
<person name="Douchain F."/>
<person name="Verchain S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS TRP-172; ALA-237 AND LYS-366</scope>
<source>
<tissue>Lymphocyte</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="1998-12" db="EMBL/GenBank/DDBJ databases">
<title>Functional prediction of the coding sequences of 32 new genes deduced by analysis of cDNA clones from human fetal liver.</title>
<authorList>
<person name="Zhang C."/>
<person name="Yu Y."/>
<person name="Zhang S."/>
<person name="Ouyang S."/>
<person name="Luo L."/>
<person name="Wei H."/>
<person name="Zhou G."/>
<person name="Zhou W."/>
<person name="Bi J."/>
<person name="Zhang Y."/>
<person name="Liu M."/>
<person name="He F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Fetal liver</tissue>
</source>
</reference>
<reference key="10">
<citation type="submission" date="2003-02" db="EMBL/GenBank/DDBJ databases">
<title>Full-length cDNA libraries and normalization.</title>
<authorList>
<person name="Li W.B."/>
<person name="Gruber C."/>
<person name="Jessee J."/>
<person name="Polayes D."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3)</scope>
<source>
<tissue>Fetal liver</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Synovium</tissue>
</source>
</reference>
<reference key="12">
<citation type="submission" date="2004-10" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT ALA-237</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Colon</tissue>
<tissue>Ovary</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="1982" name="Nature" volume="297" first="655" last="659">
<title>Sequence homology and structural comparison between the chromosomal human alpha 1-antitrypsin and chicken ovalbumin genes.</title>
<authorList>
<person name="Leicht M."/>
<person name="Long G.L."/>
<person name="Chandra T."/>
<person name="Kurachi K."/>
<person name="Kidd V.J."/>
<person name="Mace M. Jr."/>
<person name="Davie E.W."/>
<person name="Woo S.L.C."/>
</authorList>
<dbReference type="PubMed" id="6979715"/>
<dbReference type="DOI" id="10.1038/297655a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-67; 196-255 AND 387-418</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1982" name="Fed. Proc." volume="41" first="1016" last="1016">
<title>The covalent structure of human alpha1-protease inhibitor.</title>
<authorList>
<person name="Chan S.K."/>
</authorList>
</citation>
<scope>PRELIMINARY PROTEIN SEQUENCE OF 25-418 (ISOFORM 1)</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1982" name="Nature" volume="298" first="329" last="334">
<title>Structure and variation of human alpha 1-antitrypsin.</title>
<authorList>
<person name="Carrell R.W."/>
<person name="Jeppsson J.-O."/>
<person name="Laurell C.-B."/>
<person name="Brennan S.O."/>
<person name="Owen M.C."/>
<person name="Vaughan L."/>
<person name="Boswell D.R."/>
</authorList>
<dbReference type="PubMed" id="7045697"/>
<dbReference type="DOI" id="10.1038/298329a0"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-418 (ISOFORM 1)</scope>
</reference>
<reference key="17">
<citation type="submission" date="2007-08" db="UniProtKB">
<title>Appearance of an aberrant form of alpha-antitrypsin in the circulation of chronic cigarette smokers and its effect on the insulin induced NO synthesis in blood platelets.</title>
<authorList>
<person name="Sinha A.K."/>
<person name="Girish G.V."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 25-418 (ISOFORM 1)</scope>
<scope>VARIANTS ABERRANT FORM 190-GLY--ARG-198 AND VAL-288</scope>
<scope>FUNCTION</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="1991" name="Jpn. J. Cancer Res." volume="82" first="693" last="700">
<title>Characterization of a 54 kDa, alpha 1-antitrypsin-like protein isolated from ascitic fluid of an endometrial cancer patient.</title>
<authorList>
<person name="Tanaka N."/>
<person name="Sekiya S."/>
<person name="Takamizawa H."/>
<person name="Kato N."/>
<person name="Moriyama Y."/>
<person name="Fujimura S."/>
</authorList>
<dbReference type="PubMed" id="1906855"/>
<dbReference type="DOI" id="10.1111/j.1349-7006.1991.tb01905.x"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-39</scope>
<scope>FUNCTION</scope>
<source>
<tissue>Ascites</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Proteomics" volume="6" first="3369" last="3380">
<title>Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms.</title>
<authorList>
<person name="Kolarich D."/>
<person name="Weber A."/>
<person name="Turecek P.L."/>
<person name="Schwarz H.P."/>
<person name="Altmann F."/>
</authorList>
<dbReference type="PubMed" id="16622833"/>
<dbReference type="DOI" id="10.1002/pmic.200500751"/>
</citation>
<scope>PROTEIN SEQUENCE OF 30-48 AND 248-257 (ISOFORMS 1/2/3)</scope>
<scope>GLYCOSYLATION AT ASN-70; ASN-107 AND ASN-271</scope>
<scope>STRUCTURE OF CARBOHYDRATES</scope>
<scope>CYSTEINE-BINDING</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1993" name="Biochem. Biophys. Res. Commun." volume="193" first="1049" last="1053">
<title>Sequencing of a urinary stone protein, identical to alpha-one antitrypsin, which lacks 22 amino acids.</title>
<authorList>
<person name="Umekawa T."/>
<person name="Kohri K."/>
<person name="Amasaki N."/>
<person name="Yamate T."/>
<person name="Yoshida K."/>
<person name="Yamamoto K."/>
<person name="Suzuki Y."/>
<person name="Sinohara H."/>
<person name="Kurita T."/>
</authorList>
<dbReference type="PubMed" id="8323530"/>
<dbReference type="DOI" id="10.1006/bbrc.1993.1731"/>
</citation>
<scope>PROTEIN SEQUENCE OF 47-66</scope>
<source>
<tissue>Urine</tissue>
</source>
</reference>
<reference key="21">
<citation type="submission" date="2007-03" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Afjehi-Sadat L."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 50-63 AND 161-178 (ISOFORMS 1/2/3)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Brain</tissue>
<tissue>Cajal-Retzius cell</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="1985" name="FEBS Lett." volume="189" first="361" last="366">
<title>Alpha 1-antitrypsin and serum albumin mRNA accumulation in normal, acute phase and ZZ human liver.</title>
<authorList>
<person name="Riley J.H."/>
<person name="Bathurst I.C."/>
<person name="Edbrooke M.R."/>
<person name="Carrell R.W."/>
<person name="Craig R.K."/>
</authorList>
<dbReference type="PubMed" id="3876243"/>
<dbReference type="DOI" id="10.1016/0014-5793(85)81056-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 292-418 (ISOFORM 1)</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1981" name="Proc. Natl. Acad. Sci. U.S.A." volume="78" first="6826" last="6830">
<title>Cloning and sequence of cDNA coding for alpha 1-antitrypsin.</title>
<authorList>
<person name="Kurachi K."/>
<person name="Chandra T."/>
<person name="Friezner Degen S.J."/>
<person name="White T.T."/>
<person name="Marchioro T.L."/>
<person name="Woo S.L.C."/>
<person name="Davie E.W."/>
</authorList>
<dbReference type="PubMed" id="7031661"/>
<dbReference type="DOI" id="10.1073/pnas.78.11.6826"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 350-418 (ISOFORM 1)</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1992" name="Matrix" volume="12" first="233" last="241">
<title>Isolation and serine protease inhibitory activity of the 44-residue, C-terminal fragment of alpha 1-antitrypsin from human placenta.</title>
<authorList>
<person name="Niemann M.A."/>
<person name="Narkates A.J."/>
<person name="Miller E.J."/>
</authorList>
<dbReference type="PubMed" id="1406456"/>
</citation>
<scope>PROTEIN SEQUENCE OF 375-414</scope>
<scope>IDENTIFICATION OF SPAAT</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="1985" name="Biomed. Biochim. Acta" volume="44" first="421" last="431">
<title>Construction and partial characterization of a human liver cDNA library.</title>
<authorList>
<person name="Coutelle C."/>
<person name="Speer A."/>
<person name="Rogers J."/>
<person name="Kalsheker N."/>
<person name="Humphries S."/>
<person name="Williamson R."/>
</authorList>
<dbReference type="PubMed" id="3873938"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 387-418 (ISOFORM 1)</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2003" name="Nat. Biotechnol." volume="21" first="660" last="666">
<title>Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry.</title>
<authorList>
<person name="Zhang H."/>
<person name="Li X.-J."/>
<person name="Martin D.B."/>
<person name="Aebersold R."/>
</authorList>
<dbReference type="PubMed" id="12754519"/>
<dbReference type="DOI" id="10.1038/nbt827"/>
</citation>
<scope>GLYCOSYLATION AT ASN-70 AND ASN-271</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2004" name="Mol. Cell. Proteomics" volume="3" first="715" last="728">
<title>A proteomic analysis of human bile.</title>
<authorList>
<person name="Kristiansen T.Z."/>
<person name="Bunkenborg J."/>
<person name="Gronborg M."/>
<person name="Molina H."/>
<person name="Thuluvath P.J."/>
<person name="Argani P."/>
<person name="Goggins M.G."/>
<person name="Maitra A."/>
<person name="Pandey A."/>
</authorList>
<dbReference type="PubMed" id="15084671"/>
<dbReference type="DOI" id="10.1074/mcp.M400015-MCP200"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-70 AND ASN-271</scope>
<source>
<tissue>Bile</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2004" name="Proteomics" volume="4" first="454" last="465">
<title>Screening for N-glycosylated proteins by liquid chromatography mass spectrometry.</title>
<authorList>
<person name="Bunkenborg J."/>
<person name="Pilch B.J."/>
<person name="Podtelejnikov A.V."/>
<person name="Wisniewski J.R."/>
</authorList>
<dbReference type="PubMed" id="14760718"/>
<dbReference type="DOI" id="10.1002/pmic.200300556"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-70 AND ASN-271</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="2070" last="2080">
<title>Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.</title>
<authorList>
<person name="Liu T."/>
<person name="Qian W.-J."/>
<person name="Gritsenko M.A."/>
<person name="Camp D.G. II"/>
<person name="Monroe M.E."/>
<person name="Moore R.J."/>
<person name="Smith R.D."/>
</authorList>
<dbReference type="PubMed" id="16335952"/>
<dbReference type="DOI" id="10.1021/pr0502065"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-70; ASN-107 AND ASN-271</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="Mol. Cell. Proteomics" volume="5" first="226" last="233">
<title>Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach.</title>
<authorList>
<person name="Lewandrowski U."/>
<person name="Moebius J."/>
<person name="Walter U."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="16263699"/>
<dbReference type="DOI" id="10.1074/mcp.M500324-MCP200"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-70</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-70; ASN-107 AND ASN-271</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="913" last="923">
<title>A strategy for precise and large scale identification of core fucosylated glycoproteins.</title>
<authorList>
<person name="Jia W."/>
<person name="Lu Z."/>
<person name="Fu Y."/>
<person name="Wang H.P."/>
<person name="Wang L.H."/>
<person name="Chi H."/>
<person name="Yuan Z.F."/>
<person name="Zheng Z.B."/>
<person name="Song L.N."/>
<person name="Han H.H."/>
<person name="Liang Y.M."/>
<person name="Wang J.L."/>
<person name="Cai Y."/>
<person name="Zhang Y.K."/>
<person name="Deng Y.L."/>
<person name="Ying W.T."/>
<person name="He S.M."/>
<person name="Qian X.H."/>
</authorList>
<dbReference type="PubMed" id="19139490"/>
<dbReference type="DOI" id="10.1074/mcp.M800504-MCP200"/>
</citation>
<scope>GLYCOSYLATION AT ASN-107 AND ASN-271</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="Nat. Methods" volume="6" first="809" last="811">
<title>Enrichment of glycopeptides for glycan structure and attachment site identification.</title>
<authorList>
<person name="Nilsson J."/>
<person name="Rueetschi U."/>
<person name="Halim A."/>
<person name="Hesse C."/>
<person name="Carlsohn E."/>
<person name="Brinkmalm G."/>
<person name="Larson G."/>
</authorList>
<dbReference type="PubMed" id="19838169"/>
<dbReference type="DOI" id="10.1038/nmeth.1392"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-70; ASN-107 AND ASN-271</scope>
<scope>STRUCTURE OF CARBOHYDRATES</scope>
<source>
<tissue>Cerebrospinal fluid</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="1" last="17">
<title>Human urinary glycoproteomics; attachment site specific analysis of N-and O-linked glycosylations by CID and ECD.</title>
<authorList>
<person name="Halim A."/>
<person name="Nilsson J."/>
<person name="Ruetschi U."/>
<person name="Hesse C."/>
<person name="Larson G."/>
</authorList>
<dbReference type="PubMed" id="22171320"/>
<dbReference type="DOI" id="10.1074/mcp.M111.013649"/>
</citation>
<scope>GLYCOSYLATION AT ASN-70 AND ASN-271</scope>
<scope>STRUCTURE OF CARBOHYDRATES</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2015" name="Cell" volume="161" first="1619" last="1632">
<title>A single kinase generates the majority of the secreted phosphoproteome.</title>
<authorList>
<person name="Tagliabracci V.S."/>
<person name="Wiley S.E."/>
<person name="Guo X."/>
<person name="Kinch L.N."/>
<person name="Durrant E."/>
<person name="Wen J."/>
<person name="Xiao J."/>
<person name="Cui J."/>
<person name="Nguyen K.B."/>
<person name="Engel J.L."/>
<person name="Coon J.J."/>
<person name="Grishin N."/>
<person name="Pinna L.A."/>
<person name="Pagliarini D.J."/>
<person name="Dixon J.E."/>
</authorList>
<dbReference type="PubMed" id="26091039"/>
<dbReference type="DOI" id="10.1016/j.cell.2015.05.028"/>
</citation>
<scope>PHOSPHORYLATION AT SER-38</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1984" name="J. Mol. Biol." volume="177" first="531" last="556">
<title>Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function.</title>
<authorList>
<person name="Loebermann H."/>
<person name="Tokuoka R."/>
<person name="Deisenhofer J."/>
<person name="Huber R."/>
</authorList>
<dbReference type="PubMed" id="6332197"/>
<dbReference type="DOI" id="10.1016/0022-2836(84)90298-5"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS)</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1989" name="Protein Eng." volume="2" first="407" last="415">
<title>The S variant of human alpha 1-antitrypsin, structure and implications for function and metabolism.</title>
<authorList>
<person name="Engh R."/>
<person name="Loebermann H."/>
<person name="Schneider M."/>
<person name="Wiegand G."/>
<person name="Huber R."/>
<person name="Laurell C.-B."/>
</authorList>
<dbReference type="PubMed" id="2785270"/>
<dbReference type="DOI" id="10.1093/protein/2.6.407"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS)</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1995" name="FEBS Lett." volume="377" first="150" last="154">
<title>Crystal structure of an uncleaved alpha 1-antitrypsin reveals the conformation of its inhibitory reactive loop.</title>
<authorList>
<person name="Song H.K."/>
<person name="Lee K.N."/>
<person name="Kwon K.-S."/>
<person name="Yu M.-H."/>
<person name="Suh S.W."/>
</authorList>
<dbReference type="PubMed" id="8543039"/>
<dbReference type="DOI" id="10.1016/0014-5793(95)01331-8"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.46 ANGSTROMS) OF 25-418</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1996" name="Nat. Struct. Biol." volume="3" first="676" last="681">
<title>Inhibitory conformation of the reactive loop of alpha 1-antitrypsin.</title>
<authorList>
<person name="Elliott P.R."/>
<person name="Lomas D.A."/>
<person name="Carrell R.W."/>
<person name="Abrahams J.P."/>
</authorList>
<dbReference type="PubMed" id="8756325"/>
<dbReference type="DOI" id="10.1038/nsb0896-676"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 26-418</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1996" name="Structure" volume="4" first="1181" last="1192">
<title>The native strains in the hydrophobic core and flexible reactive loop of a serine protease inhibitor: crystal structure of an uncleaved alpha1-antitrypsin at 2.7 A.</title>
<authorList>
<person name="Ryu S.-E."/>
<person name="Choi H.-J."/>
<person name="Kwon K.-S."/>
<person name="Lee K.N."/>
<person name="Yu M.-H."/>
</authorList>
<dbReference type="PubMed" id="8939743"/>
<dbReference type="DOI" id="10.1016/S0969-2126(96)00126-8"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 45-418</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1998" name="J. Mol. Biol." volume="275" first="419" last="425">
<title>Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation.</title>
<authorList>
<person name="Elliott P.R."/>
<person name="Abrahams J.P."/>
<person name="Lomas D.A."/>
</authorList>
<dbReference type="PubMed" id="9466920"/>
<dbReference type="DOI" id="10.1006/jmbi.1997.1458"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 26-418</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2000" name="Nature" volume="407" first="923" last="926">
<title>Structure of a serpin-protease complex shows inhibition by deformation.</title>
<authorList>
<person name="Huntington J.A."/>
<person name="Read R.J."/>
<person name="Carrell R.W."/>
</authorList>
<dbReference type="PubMed" id="11057674"/>
<dbReference type="DOI" id="10.1038/35038119"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 48-418 IN COMPLEX WITH BOVINE TRYPSIN</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2000" name="Protein Sci." volume="9" first="417" last="420">
<title>Cleaved antitrypsin polymers at atomic resolution.</title>
<authorList>
<person name="Dunstone M.A."/>
<person name="Dai W."/>
<person name="Whisstock J.C."/>
<person name="Rossjohn J."/>
<person name="Pike R.N."/>
<person name="Feil S.C."/>
<person name="Le Bonniec B.F."/>
<person name="Parker M.W."/>
<person name="Bottomley S.P."/>
</authorList>
<dbReference type="PubMed" id="10716194"/>
<dbReference type="DOI" id="10.1110/ps.9.2.417"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 44-418</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2000" name="Protein Sci." volume="9" first="1274" last="1281">
<title>Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease.</title>
<authorList>
<person name="Elliott P.R."/>
<person name="Pei X.Y."/>
<person name="Dafforn T.R."/>
<person name="Lomas D.A."/>
</authorList>
<dbReference type="PubMed" id="10933492"/>
<dbReference type="DOI" id="10.1110/ps.9.7.1274"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS)</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2001" name="J. Mol. Biol." volume="306" first="109" last="119">
<title>A 2.1 A resolution structure of an uncleaved alpha(1)-antitrypsin shows variability of the reactive center and other loops.</title>
<authorList>
<person name="Kim S.-J."/>
<person name="Woo J.-R."/>
<person name="Seo E.J."/>
<person name="Yu M.-H."/>
<person name="Ryu S.-E."/>
</authorList>
<dbReference type="PubMed" id="11178897"/>
<dbReference type="DOI" id="10.1006/jmbi.2000.4357"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 25-418</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="46347" last="46354">
<title>Interactions causing the kinetic trap in serpin protein folding.</title>
<authorList>
<person name="Im H."/>
<person name="Woo M.-S."/>
<person name="Hwang K.Y."/>
<person name="Yu M.-H."/>
</authorList>
<dbReference type="PubMed" id="12244055"/>
<dbReference type="DOI" id="10.1074/jbc.M207682200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 25-418</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="37881" last="37887">
<title>Canonical inhibitor-like interactions explain reactivity of alpha1-proteinase inhibitor Pittsburgh and antithrombin with proteinases.</title>
<authorList>
<person name="Dementiev A."/>
<person name="Simonovic M."/>
<person name="Volz K."/>
<person name="Gettins P.G."/>
</authorList>
<dbReference type="PubMed" id="12860985"/>
<dbReference type="DOI" id="10.1074/jbc.M305195200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 26-418 OF VARIANT PITTSBURGH ARG-382</scope>
</reference>
<reference key="51">
<citation type="journal article" date="1989" name="Biosci. Rep." volume="9" first="129" last="138">
<title>Alpha 1-antitrypsin: structure, function and molecular biology of the gene.</title>
<authorList>
<person name="Kalsheker N."/>
</authorList>
<dbReference type="PubMed" id="2669992"/>
<dbReference type="DOI" id="10.1007/BF01115992"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="52">
<citation type="journal article" date="1991" name="Bioessays" volume="13" first="163" last="169">
<title>The molecular genetics of alpha 1 antitrypsin deficiency.</title>
<authorList>
<person name="Wu Y."/>
<person name="Foreman R.C."/>
</authorList>
<dbReference type="PubMed" id="1859394"/>
<dbReference type="DOI" id="10.1002/bies.950130404"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="53">
<citation type="journal article" date="1988" name="Am. J. Hum. Genet." volume="43" first="322" last="330">
<title>Characterization of the gene and protein of the common alpha 1-antitrypsin normal M2 allele.</title>
<authorList>
<person name="Nukiwa T."/>
<person name="Brantly M.L."/>
<person name="Ogushi F."/>
<person name="Fells G.A."/>
<person name="Crystal R.G."/>
</authorList>
<dbReference type="PubMed" id="2901226"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT M2</scope>
<scope>POLYMORPHISM</scope>
</reference>
<reference key="54">
<citation type="journal article" date="1990" name="Hum. Genet." volume="85" first="381" last="382">
<title>Characterisation of the alpha-1-antitrypsin M3 gene, a normal variant.</title>
<authorList>
<person name="Graham A."/>
<person name="Hayes K."/>
<person name="Weidinger S."/>
<person name="Newton C.R."/>
<person name="Markham A.F."/>
<person name="Kalsheker N.A."/>
</authorList>
<dbReference type="PubMed" id="2394452"/>
<dbReference type="DOI" id="10.1007/BF00206766"/>
</citation>
<scope>VARIANT M3 ASP-400</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1991" name="Am. J. Hum. Genet." volume="48" first="1154" last="1158">
<title>Characterization of the molecular basis of the alpha 1-antitrypsin F allele.</title>
<authorList>
<person name="Okayama H."/>
<person name="Brantly M."/>
<person name="Holmes M."/>
<person name="Crystal R.G."/>
</authorList>
<dbReference type="PubMed" id="2035534"/>
</citation>
<scope>VARIANT F CYS-247</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1989" name="Hum. Genet." volume="81" first="264" last="268">
<title>A Pro-->Leu substitution in codon 369 of the alpha-1-antitrypsin deficiency variant PI M-Heerlen.</title>
<authorList>
<person name="Hofker M.H."/>
<person name="Nukiwa T."/>
<person name="van Paassen H.M.B."/>
<person name="Nelen M."/>
<person name="Kramps J.A."/>
<person name="Klasen E.C."/>
<person name="Frants R.R."/>
<person name="Crystal R.G."/>
</authorList>
<dbReference type="PubMed" id="2784123"/>
<dbReference type="DOI" id="10.1007/BF00279001"/>
</citation>
<scope>VARIANT M-HEERLEN LEU-393</scope>
</reference>
<reference key="57">
<citation type="journal article" date="1989" name="Am. J. Hum. Genet." volume="44" first="894" last="902">
<title>In-frame single codon deletion in the M-Malton deficiency allele of alpha 1-antitrypsin.</title>
<authorList>
<person name="Fraizer G.C."/>
<person name="Harrold T.R."/>
<person name="Hofker M.H."/>
<person name="Cox D.W."/>
</authorList>
<dbReference type="PubMed" id="2786335"/>
</citation>
<scope>VARIANT M-MALTON PHE-75 DEL</scope>
</reference>
<reference key="58">
<citation type="journal article" date="1990" name="Mol. Cell. Biol." volume="10" first="47" last="56">
<title>Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin M-Mineral springs allele.</title>
<authorList>
<person name="Curiel D.T."/>
<person name="Vogelmeier C."/>
<person name="Hubbard R.C."/>
<person name="Stier L.E."/>
<person name="Crystal R.G."/>
</authorList>
<dbReference type="PubMed" id="1967187"/>
<dbReference type="DOI" id="10.1128/MCB.10.1.47"/>
</citation>
<scope>VARIANT M-MINERAL SPRINGS GLU-91</scope>
</reference>
<reference key="59">
<citation type="journal article" date="1990" name="Am. J. Hum. Genet." volume="46" first="602" last="612">
<title>Molecular analysis of the gene of the alpha 1-antitrypsin deficiency variant, M-Nichinan.</title>
<authorList>
<person name="Matsunaga E."/>
<person name="Shiokawa S."/>
<person name="Nakamura H."/>
<person name="Maruyama T."/>
<person name="Tsuda K."/>
<person name="Fukumaki Y."/>
</authorList>
<dbReference type="PubMed" id="2309708"/>
</citation>
<scope>VARIANT M-NICHINAN PHE-75 DEL</scope>
</reference>
<reference key="60">
<citation type="journal article" date="1988" name="J. Biol. Chem." volume="263" first="15528" last="15534">
<title>Characterization of the gene and protein of the alpha 1-antitrypsin 'deficiency' allele M-Procida.</title>
<authorList>
<person name="Takahashi H."/>
<person name="Nukiwa T."/>
<person name="Satoh K."/>
<person name="Ogushi F."/>
<person name="Brantly M."/>
<person name="Fells G."/>
<person name="Stier L."/>
<person name="Courtney M."/>
<person name="Crystal R.G."/>
</authorList>
<dbReference type="PubMed" id="3262617"/>
</citation>
<scope>VARIANT M-PROCIDA PRO-65</scope>
</reference>
<reference key="61">
<citation type="journal article" date="1993" name="Hum. Mutat." volume="2" first="221" last="228">
<title>Genetic diversity from a limited repertoire of mutations on different common allelic backgrounds: alpha 1-antitrypsin deficiency variant P-Duarte.</title>
<authorList>
<person name="Hildesheim J."/>
<person name="Kinsley G."/>
<person name="Bissell M."/>
<person name="Pierce J."/>
<person name="Brantly M."/>
</authorList>
<dbReference type="PubMed" id="8364590"/>
<dbReference type="DOI" id="10.1002/humu.1380020311"/>
</citation>
<scope>VARIANT P-DUARTE VAL-280</scope>
</reference>
<reference key="62">
<citation type="journal article" date="1983" name="N. Engl. J. Med." volume="309" first="694" last="698">
<title>Mutation of antitrypsin to antithrombin. Alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder.</title>
<authorList>
<person name="Owen M.C."/>
<person name="Brennan S.O."/>
<person name="Lewis J.H."/>
<person name="Carrell R.W."/>
</authorList>
<dbReference type="PubMed" id="6604220"/>
<dbReference type="DOI" id="10.1056/NEJM198309223091203"/>
</citation>
<scope>VARIANT PITTSBURGH ARG-382</scope>
</reference>
<reference key="63">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="12627" last="12632">
<title>Siiyama (serine 53 (TCC) to phenylalanine 53 (TTC)). A new alpha 1-antitrypsin-deficient variant with mutation on a predicted conserved residue of the serpin backbone.</title>
<authorList>
<person name="Seyama K."/>
<person name="Nukiwa T."/>
<person name="Takabe K."/>
<person name="Takahashi H."/>
<person name="Miyake K."/>
<person name="Kira S."/>
</authorList>
<dbReference type="PubMed" id="1905728"/>
</citation>
<scope>INVOLVEMENT IN A1ATD</scope>
<scope>VARIANT S-IIYAMA PHE-77</scope>
</reference>
<reference key="64">
<citation type="journal article" date="1990" name="Am. J. Hum. Genet." volume="46" first="810" last="816">
<title>Characterization of the normal alpha 1-antitrypsin allele V-Munich: a variant associated with a unique protein isoelectric focusing pattern.</title>
<authorList>
<person name="Holmes M.D."/>
<person name="Brantly M.L."/>
<person name="Curiel D.T."/>
<person name="Weidinger S."/>
<person name="Crystal R.G."/>
</authorList>
<dbReference type="PubMed" id="2316526"/>
</citation>
<scope>VARIANT V-MUNICH ALA-26</scope>
</reference>
<reference key="65">
<citation type="journal article" date="1990" name="Biochem. Biophys. Res. Commun." volume="170" first="1013" last="1020">
<title>Alpha 1-antitrypsin W-Bethesda: molecular basis of an unusual alpha 1-antitrypsin deficiency variant.</title>
<authorList>
<person name="Holmes M.D."/>
<person name="Brantly M.L."/>
<person name="Fells G.A."/>
<person name="Crystal R.G."/>
</authorList>
<dbReference type="PubMed" id="2390072"/>
<dbReference type="DOI" id="10.1016/0006-291X(90)90493-7"/>
</citation>
<scope>INVOLVEMENT IN A1ATD</scope>
<scope>VARIANT W-BETHESDA THR-360</scope>
</reference>
<reference key="66">
<citation type="journal article" date="1990" name="Am. J. Hum. Genet." volume="46" first="1158" last="1162">
<title>Sequence data of the rare deficient alpha 1-antitrypsin variant PI Zaugsburg.</title>
<authorList>
<person name="Faber J.-P."/>
<person name="Weidinger S."/>
<person name="Olek K."/>
</authorList>
<dbReference type="PubMed" id="2339709"/>
</citation>
<scope>VARIANT Z-AUGSBURG LYS-366</scope>
</reference>
<reference key="67">
<citation type="journal article" date="1990" name="Hum. Genet." volume="85" first="537" last="540">
<title>Molecular characterisation of two alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) Null(Newport) (Gly115-->Ser) and (Pi) Z Wrexham (Ser-19-->Leu).</title>
<authorList>
<person name="Graham A."/>
<person name="Kalsheker N.A."/>
<person name="Bamforth F.J."/>
<person name="Newton C.R."/>
<person name="Markham A.F."/>
</authorList>
<dbReference type="PubMed" id="2227940"/>
<dbReference type="DOI" id="10.1007/BF00194233"/>
</citation>
<scope>INVOLVEMENT IN A1ATD</scope>
<scope>VARIANTS Z-WREXHAM LEU-4 AND Q0-NEWPORT SER-139</scope>
</reference>
<reference key="68">
<citation type="journal article" date="1989" name="Hum. Genet." volume="84" first="55" last="58">
<title>Molecular characterisation of three alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) nullcardiff (Asp256-->Val); PiM-Malton (Phe51-->deletion) and PiI (Arg39-->Cys).</title>
<authorList>
<person name="Graham A."/>
<person name="Kalsheker N.A."/>
<person name="Newton C.R."/>
<person name="Bamforth F.J."/>
<person name="Powell S.J."/>
<person name="Markham A.F."/>
</authorList>
<dbReference type="PubMed" id="2606478"/>
<dbReference type="DOI" id="10.1007/BF00210671"/>
</citation>
<scope>VARIANTS P-CARDIFF VAL-280; I CYS-63 AND M-MALTON PHE-75 DEL</scope>
</reference>
<reference key="69">
<citation type="journal article" date="1990" name="J. Clin. Invest." volume="86" first="1878" last="1884">
<title>A null deficiency allele of alpha 1-antitrypsin, QO-Ludwigshafen, with altered tertiary structure.</title>
<authorList>
<person name="Fraizer G.C."/>
<person name="Siewertsen M.A."/>
<person name="Hofker M.H."/>
<person name="Brubacher M.G."/>
<person name="Cox D.W."/>
</authorList>
<dbReference type="PubMed" id="2254451"/>
<dbReference type="DOI" id="10.1172/JCI114919"/>
</citation>
<scope>VARIANT QO-LUDWIGSHAFEN ASN-116</scope>
</reference>
<reference key="70">
<citation type="journal article" date="1994" name="Am. J. Hum. Genet." volume="55" first="1113" last="1121">
<title>Identification and DNA sequence analysis of 15 new alpha 1-antitrypsin variants, including two PI*Q0 alleles and one deficient PI*M allele.</title>
<authorList>
<person name="Faber J.-P."/>
<person name="Poller W."/>
<person name="Weidinger S."/>
<person name="Kirchgesser M."/>
<person name="Schwaab R."/>
<person name="Bidlingmaier F."/>
<person name="Olek K."/>
</authorList>
<dbReference type="PubMed" id="7977369"/>
</citation>
<scope>VARIANTS M5-KARLSRUHE THR-58; M6-BONN PHE-69; M-PALERMO PHE-75 DEL; M6-PASSAU THR-84; M5-BERLIN THR-112; V ARG-172; M2-OBERNBURG TRP-172; L-FRANKFURT GLU-180; S-MUNICH PHE-354; P-DONAUWOERTH ASN-365 AND L-OFFENBACH THR-386</scope>
</reference>
<reference key="71">
<citation type="journal article" date="1997" name="Ann. Hum. Genet." volume="61" first="385" last="391">
<title>A new alpha 1-antitrypsin mutation, Thr-Met 85, (PI ZBristol) associated with novel electrophoretic properties.</title>
<authorList>
<person name="Lovegrove J.U."/>
<person name="Jeremiah S."/>
<person name="Gillett G.T."/>
<person name="Temple I.K."/>
<person name="Povey S."/>
<person name="Whitehouse D.B."/>
</authorList>
<dbReference type="PubMed" id="9459000"/>
<dbReference type="DOI" id="10.1017/S0003480097006404"/>
</citation>
<scope>VARIANT Z-BRISTOL MET-109</scope>
</reference>
<reference key="72">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="12" first="213" last="213">
<title>Identification and molecular characterization of the new alpha-1-antitrypsin deficient allele PI YBarcelona (Asp256Val and Pro391His).</title>
<authorList>
<person name="Jardi R."/>
<person name="Rodriguez F."/>
<person name="Miravitlles M."/>
<person name="Vidal R."/>
<person name="Cotrina M."/>
<person name="Quer J."/>
<person name="Pascual C."/>
<person name="Weidinger S."/>
</authorList>
<dbReference type="PubMed" id="10651487"/>
</citation>
<scope>VARIANTS Y-BARCELONA VAL-280 AND HIS-415</scope>
</reference>
<reference key="73">
<citation type="journal article" date="1999" name="Hum. Mutat." volume="13" first="414" last="414">
<title>A novel alpha-1-antitrypsin P362H variant found in a population sample from Sao Tome e Principe (Gulf of Guinea, West Africa).</title>
<authorList>
<person name="Seixas S."/>
<person name="Trovoada M.J."/>
<person name="Santos M.T."/>
<person name="Rocha J."/>
</authorList>
</citation>
<scope>VARIANT SAO TOME HIS-386</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2000" name="Hum. Mutat." volume="15" first="121" last="122">
<title>A novel alpha-1-antitrypsin r281del variant found in a population sample from the Basque country.</title>
<authorList>
<person name="Seixas S."/>
<person name="Garcia O."/>
<person name="Amorim A."/>
<person name="Rocha J."/>
</authorList>
<dbReference type="PubMed" id="10612848"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(200001)15:1&lt;121::AID-HUMU37>3.0.CO;2-U"/>
</citation>
<scope>VARIANT BASQUE ARG-305 DEL</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2013" name="PLoS ONE" volume="8" first="E66889" last="E66889">
<title>SERPINA2 is a novel gene with a divergent function from SERPINA1.</title>
<authorList>
<person name="Marques P.I."/>
<person name="Ferreira Z."/>
<person name="Martins M."/>
<person name="Figueiredo J."/>
<person name="Silva D.I."/>
<person name="Castro P."/>
<person name="Morales-Hojas R."/>
<person name="Simoes-Correia J."/>
<person name="Seixas S."/>
</authorList>
<dbReference type="PubMed" id="23826168"/>
<dbReference type="DOI" id="10.1371/journal.pone.0066889"/>
</citation>
<scope>VARIANTS Z ALA-237 AND LYS-366</scope>
<scope>VARIANT S VAL-288</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>GLYCOSYLATION</scope>
<scope>INTERACTION WITH CANX AND PDIA3</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2016" name="Biochem. Biophys. Res. Commun." volume="470" first="710" last="713">
<title>The M358R variant of alpha(1)-proteinase inhibitor inhibits coagulation factor VIIa.</title>
<authorList>
<person name="Sheffield W.P."/>
<person name="Bhakta V."/>
</authorList>
<dbReference type="PubMed" id="26797521"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2016.01.069"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT PITTSBURGH ARG-382</scope>
</reference>
<comment type="function">
<text>Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin and plasminogen activator. The aberrant form inhibits insulin-induced NO synthesis in platelets, decreases coagulation time and has proteolytic activity against insulin and plasmin.</text>
</comment>
<comment type="function">
<text>Short peptide from AAT: reversible chymotrypsin inhibitor. It also inhibits elastase, but not trypsin. Its major physiological function is the protection of the lower respiratory tract against proteolytic destruction by human leukocyte elastase (HLE).</text>
</comment>
<comment type="subunit">
<text evidence="9">The variants S and Z interact with CANX AND PDIA3.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-986224"/>
<interactant intactId="EBI-986224"/>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-986224"/>
<interactant intactId="EBI-986385">
<id>P00760</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-986224"/>
<interactant intactId="EBI-986248">
<id>P00772</id>
<label>CELA1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-986224"/>
<interactant intactId="EBI-2615322">
<id>P71213</id>
<label>espB</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-986224"/>
<interactant intactId="EBI-714168">
<id>P43307</id>
<label>SSR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
<subcellularLocation>
<location>Endoplasmic reticulum</location>
</subcellularLocation>
<text>The S and Z allele are not secreted effectively and accumulate intracellularly in the endoplasmic reticulum.</text>
</comment>
<comment type="subcellular location">
<molecule>Short peptide from AAT</molecule>
<subcellularLocation>
<location>Secreted</location>
<location>extracellular space</location>
<location>extracellular matrix</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P01009-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P01009-2</id>
<name>2</name>
<sequence type="described" ref="VSP_028889"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>P01009-3</id>
<name>3</name>
<sequence type="described" ref="VSP_028890"/>
<text>No experimental confirmation available. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="31">Ubiquitous. Expressed in leukocytes and plasma.</text>
</comment>
<comment type="domain">
<text>The reactive center loop (RCL) extends out from the body of the protein and directs binding to the target protease. The protease cleaves the serpin at the reactive site within the RCL, establishing a covalent linkage between the carboxyl group of the serpin reactive site and the serine hydroxyl of the protease. The resulting inactive serpin-protease complex is highly stable.</text>
</comment>
<comment type="PTM">
<text evidence="10 12 13 14 15 16 20 21 23 25 31">N-glycosylated. Differential glycosylation produces a number of isoforms. N-linked glycan at Asn-107 is alternatively di-antennary, tri-antennary or tetra-antennary. The glycan at Asn-70 is di-antennary with trace amounts of tri-antennary. Glycan at Asn-271 is exclusively di-antennary. Structure of glycans at Asn-70 and Asn-271 is Hex5HexNAc4. The structure of the antennae is Neu5Ac(alpha1-6)Gal(beta1-4)GlcNAc attached to the core structure Man(alpha1-6)[Man(alpha1-3)]Man(beta1-4)GlcNAc(beta1-4)GlcNAc. Some antennae are fucosylated, which forms a Lewis-X determinant.</text>
</comment>
<comment type="PTM">
<text>Proteolytic processing may yield the truncated form that ranges from Asp-30 to Lys-418.</text>
</comment>
<comment type="polymorphism">
<text evidence="39">The sequence shown is that of the M1V allele which is the most common form of PI (44 to 49%). Other frequent alleles are: M1A 20 to 23%; M2 10 to 11%; M3 14 to 19%.</text>
</comment>
<comment type="disease" evidence="18 26 32">
<disease id="DI-02928">
<name>Alpha-1-antitrypsin deficiency</name>
<acronym>A1ATD</acronym>
<description>A disorder whose most common manifestation is emphysema, which becomes evident by the third to fourth decade. A less common manifestation of the deficiency is liver disease, which occurs in children and adults, and may result in cirrhosis and liver failure. Environmental factors, particularly cigarette smoking, greatly increase the risk of emphysema at an earlier age.</description>
<dbReference type="MIM" id="613490"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>The aberrant form is found in the plasma of chronic smokers, and persists after smoking is ceased. It can still be found ten years after smoking has ceased.</text>
</comment>
<comment type="similarity">
<text evidence="52">Belongs to the serpin family.</text>
</comment>
<comment type="sequence caution" evidence="52">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAD62334" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="sequence caution" evidence="52">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAD62585" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Alpha_1-antitrypsin"/>
<text>Alpha-1 antitrypsin entry</text>
</comment>
<dbReference type="EMBL" id="K01396">
<property type="protein sequence ID" value="AAB59375.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="K02212">
<property type="protein sequence ID" value="AAB59495.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X01683">
<property type="protein sequence ID" value="CAA25838.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M11465">
<property type="protein sequence ID" value="AAA51546.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J02619">
<property type="protein sequence ID" value="AAA51547.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ682455">
<property type="protein sequence ID" value="ABG73380.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AM048838">
<property type="protein sequence ID" value="CAJ15161.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF113676">
<property type="protein sequence ID" value="AAF29581.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF130068">
<property type="protein sequence ID" value="AAG35496.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX161449">
<property type="protein sequence ID" value="CAD61914.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX247968">
<property type="protein sequence ID" value="CAD62306.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX248002">
<property type="protein sequence ID" value="CAD62334.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX248257">
<property type="protein sequence ID" value="CAD62585.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK315637">
<property type="protein sequence ID" value="BAG38005.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT019455">
<property type="protein sequence ID" value="AAV38262.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC011991">
<property type="protein sequence ID" value="AAH11991.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC015642">
<property type="protein sequence ID" value="AAH15642.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J00064">
<property type="protein sequence ID" value="AAB59369.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="J00066">
<property type="protein sequence ID" value="AAB59370.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="J00065">
<property type="protein sequence ID" value="AAB59370.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="J00067">
<property type="protein sequence ID" value="AAB59371.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X02920">
<property type="protein sequence ID" value="CAA26677.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="V00496">
<property type="protein sequence ID" value="CAA23755.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M26123">
<property type="protein sequence ID" value="AAA51545.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9925.1">
<molecule id="P01009-1"/>
</dbReference>
<dbReference type="PIR" id="A21853">
<property type="entry name" value="ITHU"/>
</dbReference>
<dbReference type="PIR" id="A61391">
<property type="entry name" value="A61391"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000286.3">
<molecule id="P01009-1"/>
<property type="nucleotide sequence ID" value="NM_000295.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001002235.1">
<molecule id="P01009-1"/>
<property type="nucleotide sequence ID" value="NM_001002235.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001002236.1">
<molecule id="P01009-1"/>
<property type="nucleotide sequence ID" value="NM_001002236.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001121172.1">
<molecule id="P01009-1"/>
<property type="nucleotide sequence ID" value="NM_001127700.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001121173.1">
<molecule id="P01009-1"/>
<property type="nucleotide sequence ID" value="NM_001127701.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001121174.1">
<molecule id="P01009-1"/>
<property type="nucleotide sequence ID" value="NM_001127702.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001121175.1">
<molecule id="P01009-1"/>
<property type="nucleotide sequence ID" value="NM_001127703.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001121176.1">
<molecule id="P01009-1"/>
<property type="nucleotide sequence ID" value="NM_001127704.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001121177.1">
<molecule id="P01009-1"/>
<property type="nucleotide sequence ID" value="NM_001127705.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001121178.1">
<molecule id="P01009-1"/>
<property type="nucleotide sequence ID" value="NM_001127706.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001121179.1">
<molecule id="P01009-1"/>
<property type="nucleotide sequence ID" value="NM_001127707.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016876859.1">
<molecule id="P01009-1"/>
<property type="nucleotide sequence ID" value="XM_017021370.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.525557"/>
<dbReference type="PDB" id="1ATU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=45-418"/>
</dbReference>
<dbReference type="PDB" id="1D5S">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=44-377, B=378-418"/>
</dbReference>
<dbReference type="PDB" id="1EZX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=48-382, B=383-418"/>
</dbReference>
<dbReference type="PDB" id="1HP7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=25-418"/>
</dbReference>
<dbReference type="PDB" id="1IZ2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=25-418"/>
</dbReference>
<dbReference type="PDB" id="1KCT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.46"/>
<property type="chains" value="A=25-418"/>
</dbReference>
<dbReference type="PDB" id="1OO8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A=26-418"/>
</dbReference>
<dbReference type="PDB" id="1OPH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=26-418"/>
</dbReference>
<dbReference type="PDB" id="1PSI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.92"/>
<property type="chains" value="A=26-418"/>
</dbReference>
<dbReference type="PDB" id="1QLP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=26-418"/>
</dbReference>
<dbReference type="PDB" id="1QMB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=49-376, B=377-418"/>
</dbReference>
<dbReference type="PDB" id="2D26">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A=25-382, B=383-418"/>
</dbReference>
<dbReference type="PDB" id="2QUG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=25-418"/>
</dbReference>
<dbReference type="PDB" id="3CWL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.44"/>
<property type="chains" value="A=25-418"/>
</dbReference>
<dbReference type="PDB" id="3CWM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.51"/>
<property type="chains" value="A=25-418"/>
</dbReference>
<dbReference type="PDB" id="3DRM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=26-418"/>
</dbReference>
<dbReference type="PDB" id="3DRU">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B/C=26-418"/>
</dbReference>
<dbReference type="PDB" id="3NDD">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=46-382, B=383-418"/>
</dbReference>
<dbReference type="PDB" id="3NDF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=46-382, B=383-418"/>
</dbReference>
<dbReference type="PDB" id="3NE4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.81"/>
<property type="chains" value="A=48-418"/>
</dbReference>
<dbReference type="PDB" id="3T1P">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.90"/>
<property type="chains" value="A=48-418"/>
</dbReference>
<dbReference type="PDB" id="4PYW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.91"/>
<property type="chains" value="A=26-418"/>
</dbReference>
<dbReference type="PDB" id="5IO1">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.34"/>
<property type="chains" value="A/B=29-418"/>
</dbReference>
<dbReference type="PDB" id="7API">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=36-382, B=383-418"/>
</dbReference>
<dbReference type="PDB" id="8API">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=36-382, B=383-418"/>
</dbReference>
<dbReference type="PDB" id="9API">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=36-382, B=383-418"/>
</dbReference>
<dbReference type="PDBsum" id="1ATU"/>
<dbReference type="PDBsum" id="1D5S"/>
<dbReference type="PDBsum" id="1EZX"/>
<dbReference type="PDBsum" id="1HP7"/>
<dbReference type="PDBsum" id="1IZ2"/>
<dbReference type="PDBsum" id="1KCT"/>
<dbReference type="PDBsum" id="1OO8"/>
<dbReference type="PDBsum" id="1OPH"/>
<dbReference type="PDBsum" id="1PSI"/>
<dbReference type="PDBsum" id="1QLP"/>
<dbReference type="PDBsum" id="1QMB"/>
<dbReference type="PDBsum" id="2D26"/>
<dbReference type="PDBsum" id="2QUG"/>
<dbReference type="PDBsum" id="3CWL"/>
<dbReference type="PDBsum" id="3CWM"/>
<dbReference type="PDBsum" id="3DRM"/>
<dbReference type="PDBsum" id="3DRU"/>
<dbReference type="PDBsum" id="3NDD"/>
<dbReference type="PDBsum" id="3NDF"/>
<dbReference type="PDBsum" id="3NE4"/>
<dbReference type="PDBsum" id="3T1P"/>
<dbReference type="PDBsum" id="4PYW"/>
<dbReference type="PDBsum" id="5IO1"/>
<dbReference type="PDBsum" id="7API"/>
<dbReference type="PDBsum" id="8API"/>
<dbReference type="PDBsum" id="9API"/>
<dbReference type="ProteinModelPortal" id="P01009"/>
<dbReference type="SMR" id="P01009"/>
<dbReference type="BioGrid" id="111283">
<property type="interactions" value="42"/>
</dbReference>
<dbReference type="CORUM" id="P01009"/>
<dbReference type="DIP" id="DIP-35493N"/>
<dbReference type="IntAct" id="P01009">
<property type="interactions" value="22"/>
</dbReference>
<dbReference type="MINT" id="MINT-365327"/>
<dbReference type="STRING" id="9606.ENSP00000348068"/>
<dbReference type="DrugBank" id="DB03345">
<property type="generic name" value="Beta-Mercaptoethanol"/>
</dbReference>
<dbReference type="DrugBank" id="DB05481">
<property type="generic name" value="Recombinant alpha 1-antitrypsin"/>
</dbReference>
<dbReference type="MEROPS" id="I04.001"/>
<dbReference type="iPTMnet" id="P01009"/>
<dbReference type="PhosphoSitePlus" id="P01009"/>
<dbReference type="UniCarbKB" id="P01009"/>
<dbReference type="BioMuta" id="SERPINA1"/>
<dbReference type="DMDM" id="1703025"/>
<dbReference type="DOSAC-COBS-2DPAGE" id="P01009"/>
<dbReference type="OGP" id="P01009"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00553177"/>
<dbReference type="REPRODUCTION-2DPAGE" id="P01009"/>
<dbReference type="SWISS-2DPAGE" id="P01009"/>
<dbReference type="UCD-2DPAGE" id="P01009"/>
<dbReference type="EPD" id="P01009"/>
<dbReference type="MaxQB" id="P01009"/>
<dbReference type="PaxDb" id="P01009"/>
<dbReference type="PeptideAtlas" id="P01009"/>
<dbReference type="PRIDE" id="P01009"/>
<dbReference type="DNASU" id="5265"/>
<dbReference type="Ensembl" id="ENST00000355814">
<molecule id="P01009-1"/>
<property type="protein sequence ID" value="ENSP00000348068"/>
<property type="gene ID" value="ENSG00000197249"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000393087">
<molecule id="P01009-1"/>
<property type="protein sequence ID" value="ENSP00000376802"/>
<property type="gene ID" value="ENSG00000197249"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000393088">
<molecule id="P01009-1"/>
<property type="protein sequence ID" value="ENSP00000376803"/>
<property type="gene ID" value="ENSG00000197249"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000402629">
<molecule id="P01009-2"/>
<property type="protein sequence ID" value="ENSP00000386094"/>
<property type="gene ID" value="ENSG00000197249"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000404814">
<molecule id="P01009-1"/>
<property type="protein sequence ID" value="ENSP00000385960"/>
<property type="gene ID" value="ENSG00000197249"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000437397">
<molecule id="P01009-1"/>
<property type="protein sequence ID" value="ENSP00000408474"/>
<property type="gene ID" value="ENSG00000197249"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000440909">
<molecule id="P01009-1"/>
<property type="protein sequence ID" value="ENSP00000390299"/>
<property type="gene ID" value="ENSG00000197249"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000448921">
<molecule id="P01009-1"/>
<property type="protein sequence ID" value="ENSP00000416066"/>
<property type="gene ID" value="ENSG00000197249"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000449399">
<molecule id="P01009-1"/>
<property type="protein sequence ID" value="ENSP00000416354"/>
<property type="gene ID" value="ENSG00000197249"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000489769">
<molecule id="P01009-3"/>
<property type="protein sequence ID" value="ENSP00000451525"/>
<property type="gene ID" value="ENSG00000197249"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000636712">
<molecule id="P01009-1"/>
<property type="protein sequence ID" value="ENSP00000490054"/>
<property type="gene ID" value="ENSG00000197249"/>
</dbReference>
<dbReference type="GeneID" id="5265"/>
<dbReference type="KEGG" id="hsa:5265"/>
<dbReference type="UCSC" id="uc001ycx.5">
<molecule id="P01009-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5265"/>
<dbReference type="DisGeNET" id="5265"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000197249.12"/>
<dbReference type="GeneCards" id="SERPINA1"/>
<dbReference type="GeneReviews" id="SERPINA1"/>
<dbReference type="HGNC" id="HGNC:8941">
<property type="gene designation" value="SERPINA1"/>
</dbReference>
<dbReference type="HPA" id="CAB013211"/>
<dbReference type="HPA" id="CAB016648"/>
<dbReference type="HPA" id="CAB073396"/>
<dbReference type="HPA" id="HPA000927"/>
<dbReference type="HPA" id="HPA001292"/>
<dbReference type="MalaCards" id="SERPINA1"/>
<dbReference type="MIM" id="107400">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="613490">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P01009"/>
<dbReference type="OpenTargets" id="ENSG00000197249"/>
<dbReference type="Orphanet" id="60">
<property type="disease" value="Alpha-1-antitrypsin deficiency"/>
</dbReference>
<dbReference type="Orphanet" id="178396">
<property type="disease" value="Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation"/>
</dbReference>
<dbReference type="PharmGKB" id="PA35509"/>
<dbReference type="eggNOG" id="KOG2392">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG4826">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118839"/>
<dbReference type="HOVERGEN" id="HBG005957"/>
<dbReference type="InParanoid" id="P01009"/>
<dbReference type="KO" id="K03984"/>
<dbReference type="OMA" id="FFLPDEG"/>
<dbReference type="OrthoDB" id="EOG091G0ION"/>
<dbReference type="PhylomeDB" id="P01009"/>
<dbReference type="TreeFam" id="TF343201"/>
<dbReference type="Reactome" id="R-HSA-114608">
<property type="pathway name" value="Platelet degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-204005">
<property type="pathway name" value="COPII (Coat Protein 2) Mediated Vesicle Transport"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381426">
<property type="pathway name" value="Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5694530">
<property type="pathway name" value="Cargo concentration in the ER"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8957275">
<property type="pathway name" value="Post-translational protein phosphorylation"/>
</dbReference>
<dbReference type="SIGNOR" id="P01009"/>
<dbReference type="ChiTaRS" id="SERPINA1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P01009"/>
<dbReference type="GeneWiki" id="Alpha_1-antitrypsin"/>
<dbReference type="GenomeRNAi" id="5265"/>
<dbReference type="PMAP-CutDB" id="P01009"/>
<dbReference type="PRO" id="PR:P01009"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 14"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000197249"/>
<dbReference type="ExpressionAtlas" id="P01009">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P01009">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030134">
<property type="term" value="C:COPII-coated ER to Golgi transport vesicle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005788">
<property type="term" value="C:endoplasmic reticulum lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0033116">
<property type="term" value="C:endoplasmic reticulum-Golgi intermediate compartment membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904813">
<property type="term" value="C:ficolin-1-rich granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000139">
<property type="term" value="C:Golgi membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0031093">
<property type="term" value="C:platelet alpha granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005578">
<property type="term" value="C:proteinaceous extracellular matrix"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0002020">
<property type="term" value="F:protease binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004867">
<property type="term" value="F:serine-type endopeptidase inhibitor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0006953">
<property type="term" value="P:acute-phase response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007596">
<property type="term" value="P:blood coagulation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048208">
<property type="term" value="P:COPII vesicle coating"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006888">
<property type="term" value="P:ER to Golgi vesicle-mediated transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002576">
<property type="term" value="P:platelet degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043687">
<property type="term" value="P:post-translational protein modification"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR023795">
<property type="entry name" value="Serpin_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR023796">
<property type="entry name" value="Serpin_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000215">
<property type="entry name" value="Serpin_fam"/>
</dbReference>
<dbReference type="InterPro" id="IPR036186">
<property type="entry name" value="Serpin_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11461">
<property type="entry name" value="PTHR11461"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00079">
<property type="entry name" value="Serpin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00093">
<property type="entry name" value="SERPIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56574">
<property type="entry name" value="SSF56574"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00284">
<property type="entry name" value="SERPIN"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0011">Acute phase</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0094">Blood coagulation</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0272">Extracellular matrix</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0356">Hemostasis</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0646">Protease inhibitor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0722">Serine protease inhibitor</keyword>
<keyword id="KW-0732">Signal</keyword>
<feature type="signal peptide" evidence="19">
<location>
<begin position="1"/>
<end position="24"/>
</location>
</feature>
<feature type="chain" description="Alpha-1-antitrypsin" id="PRO_0000032377" evidence="41">
<location>
<begin position="25"/>
<end position="418"/>
</location>
</feature>
<feature type="peptide" description="Short peptide from AAT" id="PRO_0000364030">
<location>
<begin position="375"/>
<end position="418"/>
</location>
</feature>
<feature type="region of interest" description="RCL">
<location>
<begin position="368"/>
<end position="392"/>
</location>
</feature>
<feature type="site" description="Reactive bond">
<location>
<begin position="382"/>
<end position="383"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by FAM20C" evidence="35">
<location>
<position position="38"/>
</location>
</feature>
<feature type="modified residue" description="S-cysteinyl cysteine">
<location>
<position position="256"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="383"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine" evidence="10 12 13 14 15 16 21 23 25">
<location>
<position position="70"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine" evidence="15 16 20 21 23">
<location>
<position position="107"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine" evidence="10 12 13 15 16 20 21 23 25">
<location>
<position position="271"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_028890" evidence="51">
<location>
<begin position="307"/>
<end position="418"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_028889" evidence="51">
<original>AVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK</original>
<variation>VRSP</variation>
<location>
<begin position="356"/>
<end position="418"/>
</location>
</feature>
<feature type="sequence variant" description="In Z-Wrexham." id="VAR_006978" evidence="26">
<original>S</original>
<variation>L</variation>
<location>
<position position="4"/>
</location>
</feature>
<feature type="sequence variant" description="In V-Munich; dbSNP:rs199422212." id="VAR_006979" evidence="29">
<original>D</original>
<variation>A</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11558262." id="VAR_051938">
<original>T</original>
<variation>A</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In M5-Karlsruhe; dbSNP:rs149319176." id="VAR_006980" evidence="44">
<original>A</original>
<variation>T</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="sequence variant" description="In I; dbSNP:rs28931570." id="VAR_006981" evidence="34">
<original>R</original>
<variation>C</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="sequence variant" description="In M-Procida; dbSNP:rs28931569." id="VAR_006982" evidence="40">
<original>L</original>
<variation>P</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="sequence variant" description="In M6-Bonn; dbSNP:rs199687431." id="VAR_006983" evidence="44">
<original>S</original>
<variation>F</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence variant" description="In M-Malton, M-Nichinan and M-Palermo; associated with very low serum levels of AAT; homozygosity for allele M-Malton may be associated with a risk for chronic emphysema or infantile liver cirrhosis." id="VAR_006984" evidence="28 34 38 44">
<location>
<position position="75"/>
</location>
</feature>
<feature type="sequence variant" description="In S-Iiyama; dbSNP:rs55819880." id="VAR_006985" evidence="18">
<original>S</original>
<variation>F</variation>
<location>
<position position="77"/>
</location>
</feature>
<feature type="sequence variant" description="In M6-Passau; dbSNP:rs111850950." id="VAR_006986" evidence="44">
<original>A</original>
<variation>T</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="In M-Mineral springs; causes reduced AAT secretion; dbSNP:rs28931568." id="VAR_006987" evidence="22">
<original>G</original>
<variation>E</variation>
<location>
<position position="91"/>
</location>
</feature>
<feature type="sequence variant" description="In QO-Lisbon; deficient AAT with very low serum levels." id="VAR_006988">
<original>T</original>
<variation>I</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence variant" description="In Z-Bristol; deficient AA; disrupts the N-glycosylation site N-107; dbSNP:rs199422213." id="VAR_011620" evidence="46">
<original>T</original>
<variation>M</variation>
<location>
<position position="109"/>
</location>
</feature>
<feature type="sequence variant" description="In M5-Berlin; dbSNP:rs886044322." id="VAR_006989" evidence="44">
<original>P</original>
<variation>T</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence variant" description="In QO-Ludwigshafen; dbSNP:rs28931572." id="VAR_006990" evidence="27">
<original>I</original>
<variation>N</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="sequence variant" description="In M2; associated with D-400; dbSNP:rs709932." id="VAR_006991">
<original>R</original>
<variation>H</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="sequence variant" description="In QO-Newport; dbSNP:rs11558261." id="VAR_006992" evidence="26">
<original>G</original>
<variation>S</variation>
<location>
<position position="139"/>
</location>
</feature>
<feature type="sequence variant" description="In V and M-Nichinan; dbSNP:rs112030253." id="VAR_006993" evidence="44">
<original>G</original>
<variation>R</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="sequence variant" description="In M2-Obernburg; dbSNP:rs112030253." id="VAR_006994" evidence="44 50">
<original>G</original>
<variation>W</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="sequence variant" description="In L-Frankfurt." id="VAR_006995" evidence="44">
<original>Q</original>
<variation>E</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In Aberrant form." id="VAR_036746">
<original>QGKIVDLVK</original>
<variation>GFQNAILVR</variation>
<location>
<begin position="190"/>
<end position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In X; dbSNP:rs199422208." id="VAR_006996">
<original>E</original>
<variation>K</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In M1A and Z; associated with K-366 in Z; dbSNP:rs6647." id="VAR_006997" evidence="17 31 47 50">
<original>V</original>
<variation>A</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In F; dbSNP:rs28929470." id="VAR_006998" evidence="24">
<original>R</original>
<variation>C</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="sequence variant" description="In P-Duarte/P-Cardiff/P-Lowell; associated with H-415 in Y-Barcelona; dbSNP:rs121912714." id="VAR_006999" evidence="8 34 45">
<original>D</original>
<variation>V</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="sequence variant" description="In S and T; dbSNP:rs17580." id="VAR_007000" evidence="31 48">
<original>E</original>
<variation>V</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence variant" description="In Basque." id="VAR_009216" evidence="7">
<location>
<position position="305"/>
</location>
</feature>
<feature type="sequence variant" description="In S-Munich; dbSNP:rs201788603." id="VAR_007001" evidence="44">
<original>S</original>
<variation>F</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="sequence variant" description="In W-Bethesda; dbSNP:rs1802959." id="VAR_007002" evidence="32">
<original>A</original>
<variation>T</variation>
<location>
<position position="360"/>
</location>
</feature>
<feature type="sequence variant" description="In P-St.Albans/P-Donauwoerth; dbSNP:rs143370956." id="VAR_007003" evidence="44">
<original>D</original>
<variation>N</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="sequence variant" description="In Z/Z-Augsburg/Z-Tun; associated with A-237 in Z; dbSNP:rs28929474." id="VAR_007004" evidence="30 31 50">
<original>E</original>
<variation>K</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="sequence variant" description="In Pittsburgh; has antithrombin activity; inhibits factor VIIa activity; causes fatal bleeding diathesis; dbSNP:rs121912713." id="VAR_007005" evidence="11 36 43">
<original>M</original>
<variation>R</variation>
<location>
<position position="382"/>
</location>
</feature>
<feature type="sequence variant" description="In Sao Tome; dbSNP:rs569384943." id="VAR_007006" evidence="49">
<original>P</original>
<variation>H</variation>
<location>
<position position="386"/>
</location>
</feature>
<feature type="sequence variant" description="In L-Offenbach; dbSNP:rs12233." id="VAR_007007" evidence="44">
<original>P</original>
<variation>T</variation>
<location>
<position position="386"/>
</location>
</feature>
<feature type="sequence variant" description="In Christchurch; dbSNP:rs121912712." id="VAR_007008">
<original>E</original>
<variation>K</variation>
<location>
<position position="387"/>
</location>
</feature>
<feature type="sequence variant" description="In M-Heerlen; dbSNP:rs199422209." id="VAR_007009" evidence="37">
<original>P</original>
<variation>L</variation>
<location>
<position position="393"/>
</location>
</feature>
<feature type="sequence variant" description="In M2 and M3; associated with H-125 in M2; dbSNP:rs1303." id="VAR_007010" evidence="17 33">
<original>E</original>
<variation>D</variation>
<location>
<position position="400"/>
</location>
</feature>
<feature type="sequence variant" description="In Y-Barcelona; associated with V-280." id="VAR_007011" evidence="8">
<original>P</original>
<variation>H</variation>
<location>
<position position="415"/>
</location>
</feature>
<feature type="mutagenesis site" description="Oxidation-resistant inhibitor of therapeutic importance." evidence="42">
<original>M</original>
<variation>V</variation>
<location>
<position position="382"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAA51546." ref="4" evidence="52">
<location>
<position position="12"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 11; BAG38005." ref="11" evidence="52">
<original>L</original>
<variation>P</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 18; AA sequence." ref="18" evidence="52">
<original>D</original>
<variation>H</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 18; AA sequence." ref="18" evidence="52">
<original>H</original>
<variation>L</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; AAF29581." ref="9" evidence="52">
<original>L</original>
<variation>P</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; ABG73380." ref="7" evidence="52">
<original>T</original>
<variation>A</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB59375." ref="1" evidence="52">
<original>GN</original>
<variation>DG</variation>
<location>
<begin position="139"/>
<end position="140"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAA51546." ref="4" evidence="52">
<original>T</original>
<variation>H</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAA51546." ref="4" evidence="52">
<original>E</original>
<variation>D</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB59375." ref="1" evidence="52">
<original>T</original>
<variation>N</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; ABG73380." ref="7" evidence="52">
<original>D</original>
<variation>G</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; CAA25838." ref="3" evidence="52">
<original>V</original>
<variation>I</variation>
<location>
<position position="326"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 24; AA sequence." ref="24" evidence="52">
<original>G</original>
<variation>L</variation>
<location>
<position position="410"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 24; AA sequence." ref="24" evidence="52">
<original>N</original>
<variation>S</variation>
<location>
<position position="414"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="48"/>
<end position="50"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="51"/>
<end position="68"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="70"/>
<end position="72"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="74"/>
<end position="76"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="78"/>
<end position="89"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="94"/>
<end position="103"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="108"/>
<end position="110"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="113"/>
<end position="127"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="135"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="146"/>
<end position="148"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="152"/>
<end position="162"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="164"/>
<end position="169"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="171"/>
<end position="173"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="174"/>
<end position="188"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="189"/>
<end position="191"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="206"/>
<end position="220"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="224"/>
<end position="226"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="228"/>
<end position="235"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="238"/>
<end position="256"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="257"/>
<end position="260"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="261"/>
<end position="279"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="280"/>
<end position="282"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="284"/>
<end position="290"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="293"/>
<end position="301"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="306"/>
<end position="313"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="315"/>
<end position="322"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="324"/>
<end position="329"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="334"/>
<end position="336"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="337"/>
<end position="339"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="343"/>
<end position="345"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="347"/>
<end position="349"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="351"/>
<end position="364"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="366"/>
<end position="381"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="387"/>
<end position="389"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="394"/>
<end position="400"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="401"/>
<end position="403"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="406"/>
<end position="414"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ATU"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1HP7"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1QMB"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3NDD"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3NE4"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10612848"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10651487"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11057674"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12754519"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12860985"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14760718"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15084671"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16263699"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16335952"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16622833"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17650587"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1905728"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1906855"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19139490"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1967187"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19838169"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2035534"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22171320"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2227940"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2254451"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2309708"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2316526"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2339709"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23826168"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2390072"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2394452"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2606478"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26091039"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26797521"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2784123"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2786335"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2901226"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3262617"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6093867"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6387509"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6604220"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7977369"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8364590"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9459000"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source ref="12"/>
</evidence>
<evidence key="48" type="ECO:0000269">
<source ref="17"/>
</evidence>
<evidence key="49" type="ECO:0000269">
<source ref="73"/>
</evidence>
<evidence key="50" type="ECO:0000269">
<source ref="8"/>
</evidence>
<evidence key="51" type="ECO:0000303">
<source ref="10"/>
</evidence>
<evidence key="52" type="ECO:0000305"/>
<sequence length="418" mass="46737" checksum="7016555F273B7F16" modified="1996-10-01" version="3" precursor="true">
MPSSVSWGILLLAGLCCLVPVSLAEDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFS
LYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGF
QELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQ
INDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTV
KVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFL
ENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKA
VLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>